A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941

Summary

The purpose of this study is to evaluate the pharmacokinetics (PK) and safety following oral administration of ASP1941 in subjects with moderate hepatic impairment and in subjects with normal hepatic function based on the Child-Pugh Classification (CPC).

Timeline

Start

2010-05

Primary completion

2010-08

Completion

2010-08

Drugs

Indications